Established in 1955, the foundation funds research and drug development, promotes individualized treatment, and ensures access to high-quality, specialized care. They manage their assets through a board of trustees and have been featured in The New York Times and The Washington Post. Thanks to their work, people with cystic fibrosis are living longer than ever before, and the foundation funds a nationwide network of care centers that have been recognized as a model of care by the National Institutes of Health. The foundation is donor-supported and accredited by the Better Business Bureau's Wise Giving Alliance.